4.1 Article

Tetracycline analogues with a selective inhibitory effect on HIF-1α

Journal

MEDCHEMCOMM
Volume 5, Issue 7, Pages 923-926

Publisher

ROYAL SOC CHEMISTRY
DOI: 10.1039/c4md00111g

Keywords

-

Funding

  1. Cancer Research UK [C180/A9327]
  2. Algerian Government

Ask authors/readers for more resources

As part of a programme to discover novel transcription factor inhibitors, a 40-membered library of tetracycline analogues was screened to identify potential HIF-1 inhibitors. Two novel analogues (5b and 5c) with significant HIF-1 modulation properties were identified. These molecules possess good cellular penetration properties, and provide significant down-regulation of VEGF in U251 cells.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.1
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Review Biochemistry & Molecular Biology

Antibody-Drug Conjugates-A Tutorial Review

Stephanie Baah, Mark Laws, Khondaker Miraz Rahman

Summary: ADCs are a family of targeted therapeutic agents for cancer treatment, with over 80 currently in clinical development and 11 approved by the FDA. They offer enhanced targeting of cancer cells and reduced toxic side effects compared to traditional approaches, making them an attractive prospect in oncology research.

MOLECULES (2021)

Article Biology

SWI/SNF subunit BAF155 N-terminus structure informs the impact of cancer-associated mutations and reveals a potential drug binding site

Mark D. Allen, Stefan M. Freund, Mark Bycroft, Giovanna Zinzalla

Summary: The crystal structure of the N-terminus of SWI/SNF chromatin remodelling factor subunit BAF155 was determined, revealing an interconnected structure of MarR-like, BRCT, and chromodomains. The study shows potential effects of cancer-associated missense mutations and suggests a binding site and target for small molecule inhibitors, offering a new strategy to target SWI/SNF complexes.

COMMUNICATIONS BIOLOGY (2021)

Article Biochemistry & Molecular Biology

Indole alkaloids from the leaves of Ravenia spectabilis engl. with activity against pancreatic cancer cell line

Fatema Tabassum, Choudhury Mahmood Hasan, Mohammad Mehedi Masud, Shirin Jamshidi, Khondaker Miraz Rahman, Monira Ahsan

Summary: Two previously undescribed indole alkaloids were isolated from the leaves of Ravenia spectabilis Engl., with 3,5-diprenyl indole exhibiting the highest cytotoxicity against human cervical cancer, pancreatic adenocarcinoma, and lung cancer cell lines. Molecular modelling studies suggested DNA intercalation as the mode of action of these compounds.

PHYTOCHEMISTRY (2021)

Article Microbiology

Schiff bases of sulphonamides as a new class of antifungal agent against multidrug-resistant Candida auris

Asad Hamad, Yiyuan Chen, Mohsin A. Khan, Shirin Jamshidi, Naima Saeed, Melanie Clifford, Charlotte Hind, J. Mark Sutton, Khondaker Miraz Rahman

Summary: In this study, a new class of antifungal agents, the Schiff bases of sulphonamides, showed activity against various Candida species, including multidrug-resistant strains causing Candidemia. These novel compounds have drug-like properties and potential for optimization with medicinal chemistry techniques to develop more potent analogs for pre-clinical evaluation.

MICROBIOLOGYOPEN (2021)

Review Pharmacology & Pharmacy

Factors influencing the choice of monoclonal antibodies for antibody-drug conjugates

Md Mahbub Hasan, Mark Laws, Peiqin Jin, Khondaker Miraz Rahman

Summary: ADCs utilize mAbs as carriers for cytotoxic payloads to target cells expressing specific antigens, but face challenges such as immunogenicity and variable drug-antibody ratios. Recent innovations and careful considerations are key to overcoming these issues and developing more effective ADC therapeutics.

DRUG DISCOVERY TODAY (2022)

Review Biochemistry & Molecular Biology

Efflux pumps in Mycobacterium tuberculosis and their inhibition to tackle antimicrobial resistance

Mark Laws, Peiqin Jin, Khondaker Miraz Rahman

Summary: Tuberculosis, caused by Mycobacterium tuberculosis, remains a major global health threat and efforts to combat drug-resistant strains are crucial. Developing efflux pump inhibitors as adjunct therapy is a key strategy in addressing resistance in TB.

TRENDS IN MICROBIOLOGY (2022)

Article Multidisciplinary Sciences

Development and exploration of novel substituted thiosemicarbazones as inhibitors of aldose reductase via in vitro analysis and computational study

Aqeel Imran, Muhammad Tariq Shehzad, Syed Jawad Ali Shah, Taha al Adhami, Mark Laws, Khondaker Miraz Rahman, Rima D. Alharthy, Imtiaz Ali Khan, Zahid Shafiq, Jamshed Iqbal

Summary: The role of aldose reductase (ALR2) in causing diabetic complications is well-studied. In this study, a series of N-substituted thiosemicarbazones with added phenolic moieties were synthesized, and compound 3m showed strong and selective ALR2 inhibitory activity in vitro as well as promising antioxidant activity. Molecular docking studies and molecular dynamics simulations confirmed the stable interactions between 3m and ALR2. Therefore, N-substituted thiosemicarbazones are potential drug candidates for selective inhibition of ALR2 and treatment of diabetic complications.

SCIENTIFIC REPORTS (2022)

Article Chemistry, Multidisciplinary

Development, Molecular Docking, and In Silico ADME Evaluation of Selective ALR2 Inhibitors for the Treatment of Diabetic Complications via Suppression of the Polyol Pathway

Aqeel Imran, Muhammad Tariq Shehzad, Syed Jawad Ali Shah, Mark Laws, Taha al-Adhami, Khondaker Miraz Rahman, Imtiaz Ali Khan, Zahid Shafiq, Jamshed Iqbal

Summary: Diabetic complications are caused by overexpression of aldose reductase, leading to oxidative stress and formation of advanced glycation end products. Current aldose reductase inhibitors have failed due to toxicity and poor pharmacokinetic profiles. This study developed thiosemicarbazone derivatives as selective inhibitors of ALR2 with antioxidant and antiglycation potential. Among the synthesized compounds, 3c showed strong and selective inhibition of ALR2, as well as good antioxidant and antiglycative properties.

ACS OMEGA (2022)

Article Biology

DNA sequence-selective G-A cross-linking ADC payloads for use in solid tumour therapies

George Procopiou, Paul J. M. Jackson, Daniella di Mascio, Jennifer L. Auer, Chris Pepper, Khondaker Miraz Rahman, Keith R. Fox, David E. Thurston

Summary: Antibody-drug conjugates (ADCs) are increasingly important in cancer treatment, and novel payloads with new mechanisms of action are in demand for enhanced therapeutic efficacy. A class of DNA-crosslinking payloads, which selectively alkylate bases in the DNA molecule, has been developed and shown to have sequence-specific cytotoxicity. When conjugated to an antibody, the ADC exhibits significant antitumor activity and high tolerability.

COMMUNICATIONS BIOLOGY (2022)

Article Pharmacology & Pharmacy

Stimulation of platelet P2Y1 receptors by different endogenous nucleotides leads to functional selectivity via biased signalling

Kate L. Arkless, Dingxin Pan, Manu Shankar-Hari, Richard T. Amison, Clive P. Page, Khondaker Miraz Rahman, Simon C. Pitchford

Summary: This study compared the effects of ADP, Ap3A, NAD(+), ADP-ribose, and Up4A on platelet functions, and found that these endogenous nucleotides can modulate platelet's inflammatory functions through activating P2Y(1) receptors, but have different effects on thrombotic functions. Molecular docking analysis revealed distinct differences in amino acid interactions and depth of fit within the binding pocket between these nucleotides and ADP.

BRITISH JOURNAL OF PHARMACOLOGY (2023)

Article Infectious Diseases

Covalent DNA Binding Is Essential for Gram-Negative Antibacterial Activity of Broad Spectrum Pyrrolobenzodiazepines

Pietro Picconi, Charlotte K. Hind, J. Mark Sutton, Khondaker Miraz Rahman

Summary: Finding new antibiotic classes against multidrug-resistant bacteria is urgently needed. Pyrrolobenzodiazepines (PBDs) with a C8-linked aliphatic-heterocycle have recently been identified as a new broad-spectrum antibiotic class with activity against Gram-negative bacteria. By replacing the active imine moiety of lead PBD compounds with amide, non-DNA binding and noncytotoxic dilactam analogues were obtained to improve the safety potential of this class.

ANTIBIOTICS-BASEL (2022)

Article Biochemistry & Molecular Biology

Identification and characterisation of G-quadruplex DNA-forming sequences in the Pseudomonas aeruginosa genome

Lindsay Evans, Anita Kotar, Martina Valentini, Alain Filloux, Shirin Jamshidi, Janez Plavec, Khondaker Miraz Rahman, Ramon Vilar

Summary: This study discovered three stable guanine-quadruplex structures in the genome of Pseudomonas aeruginosa and demonstrated that small molecules can stabilize these structures under physiological conditions. These findings could be important for the development of new antibiotics to combat antimicrobial resistance.

RSC CHEMICAL BIOLOGY (2023)

Review Infectious Diseases

Evaluation of Antibiotic Resistance Mechanisms in Gram-Negative Bacteria

Anusha Gauba, Khondaker Miraz Rahman

Summary: Multidrug-resistant Gram-negative bacterial infections pose a serious global healthcare and economic threat. The lack of new therapies and the increasing resistance levels call for urgent research and development of novel targeted therapies. Efforts have been made to combat antibiotic resistance by targeting specific mechanisms, but further research is needed to understand the precise mechanisms and explore narrow-spectrum targeted therapies.

ANTIBIOTICS-BASEL (2023)

Article Biochemistry & Molecular Biology

Mechanistic insight into the repair of C8-linked pyrrolobenzodiazepine monomer-mediated DNA damage

Asha Mary Joseph, Kazi Nahar, Saheli Daw, Md. Mahbub Hasan, Rebecca Lo, Tung B. K. Le, Khondaker Miraz Rahman, Anjana Badrinarayanan

Summary: Pyrrolobenzodiazepines (PBDs) are DNA binding compounds with anti-tumor and anti-bacterial activity. Chemical modifications can enhance their DNA binding and efficacy. Our study shows that PBD monomers cause DNA damage and kill bacteria, and repairing these damages rely on error-free mechanisms.

RSC MEDICINAL CHEMISTRY (2022)

Article Chemistry, Medicinal

A New Cyclohexanone Derivative from the Leaves of Bridelia stipularis

K. R. Shahriar, M. E. Hossain, K. M. Rahman, M. Ahsan, C. M. Hasan

Summary: A new cyclohexanone derivative named stipularone was isolated from the leaves of Bridelia stipularis and characterized using NMR spectroscopy and HR-ESI-MS. Additionally, four known compounds were identified by comparing their spectra with published results, and the chemotaxonomic significance of the isolated compounds was discussed.

CHEMISTRY OF NATURAL COMPOUNDS (2021)

No Data Available